FDA Warning Letter: MedOffice Saglik Endustri Anonim Sirketi
he FDA inspection at MedOffice Saglik Endustri Anonim Sirketi revealed significant CGMP violations that could jeopardize product quality and consumer safety. Issues ranged from inadequate testing of drug products to…
10 Tips on How to Prepare for a GMP Inspection
Prepare for GMP inspections with these 10 tips, including audits, updated documentation, staff training, mock inspections, and setting up a war room.
Powders, Granules, and Tablets: What is the Difference
Explore the key differences between powders, granules, and tablets in pharmaceuticals, including their advantages, disadvantages, and manufacturing approaches.
Draft EDQM General Chapter 5.38: Quality of Data
EDQM releases draft chapter 5.38 on data quality in pharma, emphasizing standards, governance, and SME involvement.
Out of Trend (OOT) Results in Pharma Industry
Learn how to detect, manage, and investigate Out-of-Trend (OOT) results in pharma to maintain product quality, ensure GMP compliance, and prevent OOS issues.
Toxic Solvents Used in Reversed Phase Chromatography
Explore the impact of toxic solvents in Reversed Phase Chromatography, their risks, and eco-friendly alternatives to ensure safe, accurate testing in pharmaceutical QC labs while minimizing environmental hazards.
FEFO vs FIFO vs LIFO: What Is the Difference?
Discover the key differences between FEFO, FIFO, and LIFO in pharmaceutical inventory management. Learn how each method impacts regulatory compliance, product quality, and operational efficiency in GMP/GDP-regulated warehouses.
FDA Warning Letter Analysis: Diamond Chemical Co., Inc.
FDA issues a Warning Letter to Diamond Chemical Co., Inc. for cGMP violations, highlighting deficiencies in component testing, batch release, process validation, and stability testing. Explore the corrective actions and…
Types of Sampling Methods in Environmental Monitoring
Explore key sampling methods in environmental monitoring, like air, surface, and personnel sampling, to ensure GMP compliance and maintain cleanroom product safety.
Bionpharma Inc. Recalls Batch of Atovaquone Oral Suspension Due to Contamination
Bionpharma Inc. has issued a recall for Atovaquone Oral Suspension due to contamination with Cohnella bacteria.